Compounds for the treatment of Hepatitis C

US7547690B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Robert G. Gentles · Killingworth, US
• Xiaofan Zheng · Cheshire, US
• Min Ding · Dobbs Ferry, US
• Yong Tu · Cheshire, US
• Ying Han · Cheshire, US
• Piyasena Hewawasam · Middletown, US
• John F. Kadow · Wallingford, US
• John A. Bender · Middletown, US
• Kap-Sun Yeung · Madison, US
• Katharine A. Grant-Young · Madison, US
• Thomas W. Hudyma · Durham, US

Key dates

• Filing date: Feb 28, 2008
• Grant date: Jun 16, 2009
• Expiry date: Feb 28, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention encompasses compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.